Department of Anesthesiology, University of Wisconsin, Madison, WI, USA.
University College London/University College London Hospital National Institute of Health Research Biomedical Research Centre, London, UK.
Br J Anaesth. 2019 May;122(5):552-562. doi: 10.1016/j.bja.2019.01.018. Epub 2019 Mar 2.
A multidisciplinary international working subgroup of the third Perioperative Quality Initiative consensus meeting appraised the evidence on the influence of preoperative arterial blood pressure and community cardiovascular medications on perioperative risk.
A modified Delphi technique was used, evaluating papers published in MEDLINE on associations between preoperative numerical arterial pressure values or cardiovascular medications and perioperative outcomes. The strength of the recommendations was graded by National Institute for Health and Care Excellence guidelines.
Significant heterogeneity in study design, including arterial pressure measures and perioperative outcomes, hampered the comparison of studies. Nonetheless, consensus recommendations were that (i) preoperative arterial pressure measures may be used to define targets for perioperative management; (ii) elective surgery should not be cancelled based solely upon a preoperative arterial pressure value; (iii) there is insufficient evidence to support lowering arterial pressure in the immediate preoperative period to minimise perioperative risk; and (iv) there is insufficient evidence that any one measure of arterial pressure (systolic, diastolic, mean, or pulse) is better than any other for risk prediction of adverse perioperative events.
Future research should define which preoperative arterial pressure values best correlate with adverse outcomes, and whether modifying arterial pressure in the preoperative setting will change the perioperative morbidity or mortality. Additional research should define optimum strategies for continuation or discontinuation of preoperative cardiovascular medications.
第三届围手术期质量倡议共识会议的一个多学科国际工作组对术前动脉血压和社区心血管药物对围手术期风险的影响证据进行了评估。
采用改良 Delphi 技术,评估 MEDLINE 上发表的关于术前数值性动脉压值或心血管药物与围手术期结局之间关系的论文。根据英国国家卫生与保健优化研究所指南对推荐建议的强度进行分级。
研究设计存在显著的异质性,包括动脉压测量和围手术期结局,这妨碍了研究之间的比较。尽管如此,仍达成了以下共识建议:(i)术前动脉压测量值可用于定义围手术期管理的目标;(ii)不应仅基于术前动脉压值取消择期手术;(iii)没有足够的证据支持在术前期间降低动脉压以最小化围手术期风险;(iv)没有足够的证据表明任何一种动脉压(收缩压、舒张压、平均压或脉搏)在预测不良围手术期事件风险方面优于其他动脉压。
未来的研究应确定哪些术前动脉压值与不良结局的相关性最佳,以及在术前调整动脉压是否会改变围手术期发病率或死亡率。还需要进一步的研究来确定继续或停止术前心血管药物的最佳策略。